Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Surgical Wound Infection 4Colorectal Neoplasms 4Neoplasms 3Sepsis 2Pancreatic Neoplasms 2Leukemia, Myeloid, Acute 2Febrile Neutropenia 2Triple Negative Breast Neoplasms 1Solitary Pulmonary Nodule 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Fistula 1Neutropenia 1Neoplasms, Plasma Cell 1Multiple Pulmonary Nodules 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lung Neoplasms 1Intestinal Neoplasms 1Inflammation 1Infections 1Glioblastoma 1Fever 1Exanthema 1Emergencies 1Duodenal Neoplasms 1Discitis 1Diarrhea 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 330Pemetrexed 266Cisplatin 234Docetaxel 195Paclitaxel 182Radiotherapy 181Erlotinib Hydrochloride 153pembrolizumab 147Gemcitabine 147Bevacizumab 125Drug Therapy 121Radiosurgery 115Nivolumab 112osimertinib 92durvalumab 88Gefitinib 67atezolizumab 63Vinorelbine 63Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 54anlotinib 42Immunotherapy 42Taxes 39Blood Specimen Collection 39Ipilimumab 38130-nm albumin-bound paclitaxel 38Specimen Handling 36Immune Checkpoint Inhibitors 35Radiation 34Albumin-Bound Paclitaxel 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Non-Small-Cell Lung × Anti-Bacterial Agents × Clear all
NCT00932152 2017-10-19

Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer

University of Pittsburgh

Phase 2 Terminated
3 enrolled 6 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡